High-risk Patients Following Hospitalisation for an Acute Exacerbation of COPD
Overview
Authors
Affiliations
The aim of this study was to assess long-term mortality and predictive factors of death after hospital admission for acute exacerbation of chronic obstructive pulmonary disease (COPD). 1824 patients (23.2% female; mean age 70.3±11.3 years) consecutively admitted for acute exacerbation of COPD in the respiratory medicine departments of 68 general hospitals between October 2006 and June 2007 were prospectively enrolled in a follow-up cohort. Their vital status was documented between October 2010 and April 2011. Vital status was available for 1750 patients (95.9%), among whom 787 (45%) died during follow-up. Multivariate analysis found that age (60-80 years and ≥80 years versus <60 years, relative risk 2.99, 95% CI 2.31-3.89), lower body mass index (25-30 kg·m(-2) versus ≤20 kg·m(-2), relative risk 0.80, 95% CI 0.66-0.97), lung cancer (relative risk 2.08, 95% CI 1.43-3.01), cardiovascular comorbidity (relative risk 1.35, 95% CI 1.16-1.58), previous hospital admissions for acute exacerbation of COPD (four or more versus none, relative risk 1.91, 95% CI 1.44-2.53), use of accessory respiratory muscles (relative risk 1.19, 95% CI 1.01-1.40) or lower-limb oedema (relative risk 1.74, 95% CI (1.44-2.12)) at admission and treatment by long-term oxygen therapy at discharge (relative risk 2.09, 95% CI 1.79-2.45) were independent risk factors of death. Mortality rate during the 4 years following hospital admission for acute exacerbation of COPD was high (45%). Simple clinical information relating to respiratory and general status can help in identifying high-risk patients and targeting more intensive follow-up and care. Interestingly, cardiovascular comorbidities and past hospitalisations for acute exacerbation of COPD, but not forced expiratory volume in 1 s, independently predicted the risk of death.
Early Identification of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease (COPD).
Voulgareli I, Antonogiannaki E, Bartziokas K, Zaneli S, Bakakos P, Loukides S J Clin Med. 2025; 14(2).
PMID: 39860403 PMC: 11765565. DOI: 10.3390/jcm14020397.
The impact of body mass index on mortality in COPD: an updated dose-response meta-analysis.
Tenda E, Henrina J, Setiadharma A, Felix I, Yulianti M, Pitoyo C Eur Respir Rev. 2024; 33(174).
PMID: 39603663 PMC: 11600125. DOI: 10.1183/16000617.0261-2023.
Yang C, Sun M, Xu G, Luo Q, Huang L, Tian H Front Public Health. 2023; 11:1235672.
PMID: 37849714 PMC: 10578458. DOI: 10.3389/fpubh.2023.1235672.
Rochester C, Alison J, Carlin B, Jenkins A, Cox N, Bauldoff G Am J Respir Crit Care Med. 2023; 208(4):e7-e26.
PMID: 37581410 PMC: 10449064. DOI: 10.1164/rccm.202306-1066ST.
Enaud R, Sioniac P, Imbert S, Janvier P, Camino A, Bui H Microbiol Spectr. 2023; :e0506222.
PMID: 36976010 PMC: 10100765. DOI: 10.1128/spectrum.05062-22.